Laboratory Services

 

German election threat to whole healthcare system

Potential winners of Germany's upcoming elections are pledging to abolish private medical insurance (PKV). The move could spell disaster for the whole healthcare sector: it accounts for 37% of all expenditure.

FREE BLOG What will B2C diagnostics sector do post Covid?

The direct-to-consumer or B2C diagnostics sector began well before Covid. Over the past decade, increasing numbers of people have used at-home testing kits to screen for a variety of diseases (cancers, cardiac diseases and STIs), as well as to evaluate genetic susceptibility and find out about their ancestry.

Dutch lab consolidation to resume after COVID blip

The consolidation of The Netherlands' non-profit outpatient diagnostics sector by for-profit groups is expected to pick up in the coming months after a delay due to Covid, a partner at Deloitte tells HBI.

Market conditions right for Unilabs to sell

HBI hears rumour that pan-European laboratory and imaging group Unilabs could sell soon. We explore how its private equity owner Apax could make a much-anticipated exit. 

How outsiders grabbed the holiday COVID-19 testing market

While sales and profits at Europe's largest traditional players swelled during the pandemic, the sector also saw an influx of non-traditional players. The trend has seen biotech companies start to sell their COVID-19 tests direct to the customer.

Rede D’Or backs down on Alliar

Brazilian hospital group Rede D'Or has pulled back on its attempt to takeover imaging group Alliar after it became clear it could not take control. However, large lab group Fleury has now also thrown its hat into the ring for a stake.

Rede D’Or bids for Alliar

Brazil's largest hospital group Rede D'Or has launched a takeover bid for one of the country's largest diagnostic groups Alliar. 

Find Us